Suzanne Gazda

2.0k total citations
13 papers, 1.0k citations indexed

About

Suzanne Gazda is a scholar working on Pathology and Forensic Medicine, Neurology and Infectious Diseases. According to data from OpenAlex, Suzanne Gazda has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Neurology and 4 papers in Infectious Diseases. Recurrent topics in Suzanne Gazda's work include Multiple Sclerosis Research Studies (5 papers), Parasitic Diseases Research and Treatment (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Suzanne Gazda is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Parasitic Diseases Research and Treatment (4 papers) and Peripheral Neuropathies and Disorders (3 papers). Suzanne Gazda collaborates with scholars based in United States, Uganda and Canada. Suzanne Gazda's co-authors include Douglas L. Arnold, Amit Bar‐Or, Neena Sarkar, Emmanuelle Waubant, Robert J. Fox, Sunil Agarwal, Clyde Markowitz, Michael Panzara, Craig H. Smith and Lloyd H. Kasper and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

Suzanne Gazda

13 papers receiving 987 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Suzanne Gazda 621 362 273 225 166 13 1.0k
Claire Hirst 900 1.4× 238 0.7× 374 1.4× 189 0.8× 267 1.6× 27 1.2k
P. O’Connor 783 1.3× 233 0.6× 221 0.8× 242 1.1× 152 0.9× 16 1.0k
Anton Vladić 452 0.7× 199 0.5× 218 0.8× 190 0.8× 141 0.8× 26 726
David Brassat 912 1.5× 256 0.7× 458 1.7× 172 0.8× 243 1.5× 41 1.2k
Jacqueline Yaouanq 592 1.0× 269 0.7× 204 0.7× 148 0.7× 302 1.8× 39 1.6k
P Cortinovis-Tourniaire 909 1.5× 874 2.4× 160 0.6× 237 1.1× 193 1.2× 5 1.5k
Gillian Ingram 964 1.6× 388 1.1× 346 1.3× 185 0.8× 299 1.8× 38 1.3k
Sandrine Wiertlewski 740 1.2× 428 1.2× 447 1.6× 140 0.6× 171 1.0× 48 1.2k
Andreas Lossius 394 0.6× 284 0.8× 71 0.3× 121 0.5× 99 0.6× 26 723
А. Н. Бойко 707 1.1× 247 0.7× 248 0.9× 169 0.8× 228 1.4× 75 995

Countries citing papers authored by Suzanne Gazda

Since Specialization
Citations

This map shows the geographic impact of Suzanne Gazda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Gazda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Gazda more than expected).

Fields of papers citing papers by Suzanne Gazda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Gazda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Gazda. The network helps show where Suzanne Gazda may publish in the future.

Co-authorship network of co-authors of Suzanne Gazda

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Gazda. A scholar is included among the top collaborators of Suzanne Gazda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Gazda. Suzanne Gazda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Gazda, Suzanne, et al.. (2018). Could nodding syndrome in Northern Uganda be a form of autism spectrum disorder? an observational study design. Pan African Medical Journal. 30. 115–115. 7 indexed citations
2.
Palmer, Valerie S., et al.. (2018). A real-time medical cartography of epidemic disease (Nodding syndrome) using village-based lay mHealth reporters. PLoS neglected tropical diseases. 12(6). e0006588–e0006588. 13 indexed citations
3.
Gazda, Suzanne & David Lagoro Kitara. (2018). Treatment and rehabilitation outcomes of children affected with nodding syndrome in Northern Uganda: a descriptive case series. Pan African Medical Journal. 29. 228–228. 8 indexed citations
4.
Spencer, Peter S., David Lagoro Kitara, Suzanne Gazda, & Andrea Sylvia Winkler. (2015). Nodding syndrome: 2015 International Conference Report and Gulu Accord. SHILAP Revista de lepidopterología. 3. 80–83. 18 indexed citations
5.
Kitara, David Lagoro, et al.. (2015). Nodding Episodes and High Anion Gap in a 13 Year Old Child with Nodding Syndrome: A Case Report. British Journal of Medicine and Medical Research. 6(8). 851–858. 3 indexed citations
6.
Coles, Alasdair, Edward Fox, Anton Vladić, et al.. (2012). Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial. Neurology. 78(14). 1069–1078. 193 indexed citations
7.
Fox, Edward, et al.. (2011). A single‐arm, open‐label study of alemtuzumab in treatment‐refractory patients with multiple sclerosis. European Journal of Neurology. 19(2). 307–311. 39 indexed citations
8.
Coles, Alasdair, Edward Fox, Anton Vladić, et al.. (2011). Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. The Lancet Neurology. 10(4). 338–348. 101 indexed citations
9.
Simpson, David M., Suzanne Gazda, Stephen Brown, et al.. (2010). Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain. Journal of Pain and Symptom Management. 39(6). 1053–1064. 79 indexed citations
10.
11.
Arnold, Douglas L., Denise I. Campagnolo, Hillel Panitch, et al.. (2008). Glatiramer acetate after mitoxantrone induction improves MRI markers of lesion volume and permanent tissue injury in MS. Journal of Neurology. 255(10). 1473–1478. 23 indexed citations
12.
Bar‐Or, Amit, Peter A. Calabresi, Douglas L. Arnold, et al.. (2008). Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial. Annals of Neurology. 63(3). 395–400. 419 indexed citations
13.
Gilliam, Frank, Felix Veloso, M.A.M. Bomhof, et al.. (2003). A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology. 60(2). 196–202. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026